ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. - Wikidata - wikimedia - TriplyDB

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

http://www.wikidata.org/entity/Q33252737

about

Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review Antiepileptic drug monotherapy for epilepsy: a network meta-analysis Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review Clobazam monotherapy for partial-onset or generalized-onset seizures Traditional Chinese medicine for epilepsy Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures Oxcarbazepine versus phenytoin monotherapy for epilepsy Traditional Chinese medicine for epilepsy Development of lacosamide for the treatment of partial-onset seizures Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.Causal inference as an emerging statistical approach in neurology: an example for epilepsy in the elderly.Quality improvement in neurology: Epilepsy Update Quality Measurement Set.Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.Packages of care for epilepsy in low- and middle-income countries.Disrupted Structural and Functional Networks and Their Correlation with Alertness in Right Temporal Lobe Epilepsy: A Graph Theory Study.Identification of pharmacoresistant epilepsy.Parent and family stress factors predict health-related quality in pediatric patients with new-onset epilepsy.Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07 What are the Therapeutic Advances in Neurology? Opinions from World Experts.Comparing drug treatments in epilepsy.Treating epilepsy across its different stages.Practice Update: Review of Anticonvulsant Therapy.Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.Oxcarbazepine for refractory epilepsy: systematic review of the literature.Emerging drugs for epilepsy.Seizures in patients with cerebral hemiatrophy: A prognostic evaluation Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters.Treatment of epilepsy in China: Formal or informal.Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis

P2860

Q24185852-4A3EE733-FBC1-4862-A39D-2693EDA6D844 Q24186327-D015AE04-D00E-4553-9F7F-FD639EBBC9A3 Q24186683-8B96645B-60D2-4FEC-9EDD-604D846CF8CC Q24187678-ADB9A742-26D3-4769-82B9-B0CEAB1640FD Q24187872-D909DC45-0F59-42A8-AA89-7650104F5A74 Q24193187-04CB7176-4E40-424D-86EE-F208E280AF0B Q24198162-BE83BEB9-572E-4C37-9FF8-C4E8893CD85C Q24200276-5AF0B507-8693-48A1-AD90-6D80D690C7ED Q24201696-2DF4BED9-4A19-4250-BA67-12B5F1CF67A2 Q24202768-E7ADAFD4-5E76-4CA0-B9A9-DDC4ED6AF0BA Q24240082-952FB554-D7FE-4881-A021-0A88B80DEE6A Q24629140-1D3D0FE0-AAFF-4223-BE6F-E57B3FE617F7 Q24630240-A090BEF5-8406-44D2-865D-3CC91BDB6FD5 Q26783200-EE546C63-8CF7-45B5-B770-A08642958FC4 Q26995736-7C53540A-28B8-4274-A387-731517C9F576 Q27693823-2EC6E1DA-04C7-4B88-A841-AC5A0A2DE064 Q30238821-74D2D497-A422-4EB7-930F-4FC7EDDB69B3 Q30300230-BF353419-DA0C-48C6-9739-D9E0A22E4200 Q31142199-75AE8942-094D-4551-9EEF-B063F7778DAE Q31147165-70C23A4E-025E-4CAA-AB2D-EEFA23B5FBD5 Q31166723-82619006-7A97-4066-B84C-0B83F632FDAF Q33510133-0DBB708B-2698-4304-BC5C-F655CC729A7B Q33627906-CFBE8DE4-0EDB-453C-B0D4-8C462838FAB6 Q33682111-EEB4FC47-352E-4B8C-973D-C3110B37C253 Q33756762-EF3582CF-64F3-444D-9174-8B67D03D831E Q34180457-397F69EC-FF63-47FE-A304-62192CF66A8E Q34409057-32A3F378-FFEE-43A2-8372-0F53E0BD78B6 Q34409373-1C24BC46-B609-4DAE-9167-266BDFCED3F9 Q34409465-1D600D03-58FF-4157-BDD7-50857B80BF98 Q34518509-3037EC60-B3C0-420B-A639-24F6DC74050B Q34547394-E62B4035-8BDF-41DA-ADE4-0BBD7D040D25 Q34612641-4AFDB67D-459B-4AE6-8888-2D11A313A371 Q34688725-B594D2E9-6ADE-4CF4-AC7F-E59F09B2DFAA Q35149182-245A0944-F781-4BD8-A941-13C7CDF346D4 Q35204659-DAB6AC68-123B-4BE8-A268-8095606A8021 Q35245431-D4FC1031-4FB1-497C-923F-C4D1A3015BC8 Q35686045-FB47247C-06BF-4530-8D8F-11F0A6583E41 Q35757818-F45F2421-4822-4682-933B-FF5CE0A76E15 Q35758344-D78907EF-F1AE-4F01-87F6-3C253E9FA41D Q35886881-BF69236A-A521-443B-9EF4-55BDCC173934

P2860

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

http://www.wikidata.org/entity/Q33252737

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@ast

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@en

type

label

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@ast

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@en

prefLabel

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@ast

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@en

P1433

Q33252737-669B8726-4353-4913-9AD6-28827E767D52

P1476

Q33252737-7F1BD2AB-D999-4A0B-855C-60EC8DC752B3

P2093

Q33252737-184D64D0-BAC1-466F-80BB-392C0D024753

Q33252737-34581798-B5DB-4FC9-A1E0-E56FC0D4BD1D

Q33252737-39FD1B68-CA55-4E8F-8BD5-878D0BA6FAEF

Q33252737-422DAAE5-8E15-431B-A453-63ABA9CDCBBB

Q33252737-5A3B6C91-2B16-4631-8EA3-060EE6762838

Q33252737-858F54C1-B0D2-409C-84E0-1C8E3360AB70

Q33252737-C5D63130-AA9D-40A9-B9E5-1081564618BC

Q33252737-F46C7177-62CA-402D-8A3F-A6EB9D963801

P2860

Q33252737-04DEECDF-DBD3-4D66-BE12-39B46548D3E4

Q33252737-089C02F3-490F-441C-87E1-3A2D2774E2CA

Q33252737-1864A0A1-47F0-4D1C-9A44-0986109927A3

Q33252737-1A86E38B-B1FF-4343-8893-653D879BAFD9

Q33252737-1E171F4D-5980-4C07-BB04-3C53EC4AC584

Q33252737-1EDA096C-2A66-4865-B2C1-D87B4CC5620B

Q33252737-206D7117-F5BE-4D82-AA87-5EF43DAC6B89

Q33252737-282D1C92-7651-4AFB-A87E-A79D251FE449

Q33252737-2C546ECC-A572-473C-8E91-CFD6F098C913

Q33252737-2D2ABA88-63BC-4D6C-AF56-B528E637E1D6

P304

Q33252737-A725B58C-8A63-46E4-9479-33AFC6766324

P31

Q33252737-DB6102F8-03FB-4B4A-B7E4-2F354DD4E4AF

P356

Q33252737-4677F6B9-D13A-4DC2-BA48-9CD0C97B02FC

P433

Q33252737-ED263D9C-F51B-4B5A-A5A0-7C70E12A65A0

P478

Q33252737-E57E6934-FECA-4CA6-BCE4-85B853BFB090

P50

Q33252737-56DC1F01-1766-49DD-B2CF-D87A24B97D9D

Q33252737-7B4FA960-EB37-4D98-979D-5D9A84CA2F96

P577

Q33252737-1518A8D6-EA18-4B1E-B5F9-3A595D9D328F

P5875

Q33252737-95B49084-20FF-4B8B-A22C-3B9840AFF92D

P698

Q33252737-775DCC5D-4A7D-42D8-BBC9-FAD774338977

P356

J.1528-1167.2006.00585.X

P1433

P1476

ILAE treatment guidelines: evi ...... leptic seizures and syndromes.

@en

P2093

Avital Cnaan

http://www.w3.org/2001/XMLSchema#string

Blaise Bourgeois

http://www.w3.org/2001/XMLSchema#string

Carlos Guerreiro

http://www.w3.org/2001/XMLSchema#string

David Chadwick

http://www.w3.org/2001/XMLSchema#string

Elinor Ben-Menachem

http://www.w3.org/2001/XMLSchema#string

Reetta Kalviainen

http://www.w3.org/2001/XMLSchema#string

Richard Mattson

http://www.w3.org/2001/XMLSchema#string

Tracy Glauser

http://www.w3.org/2001/XMLSchema#string

P2860

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis.

Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American E

When antiepileptic drugs aggravate epilepsy.

Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards.

Allocation concealment in randomised trials: defending against deciphering.

Indication for anterior temporal lobectomy in patients with temporal lobe epilepsy and psychopathology.

Estimating the costs of epilepsy: an international comparison of epilepsy cost studies.

A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.

P304

1094-1120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1528-1167.2006.00585.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Torbjörn Tomson

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6899792

http://www.w3.org/2001/XMLSchema#string

P698

16886973

http://www.w3.org/2001/XMLSchema#string